Retinoic acid-OVA
Retinoic acid-OVA is a conjugate of Retinoic acid and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Product Specifications
UNSPSC
12352100
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
[Retinoicacid-OVA]
References & Citations
[1]Wu L, et al. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis. PLoS One. 2016 Apr 14;11 (4) :e0153556.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882037-100 1x 100 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2037), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740049-100 1x 100 µL
CD31 / PECAM-1 (C31.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0806-100 1x 100 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682342-500 1x 500 µL
Calcineurin B / PPP3R1 (CALNB/2342), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details